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Aims: In polycystic ovary syndrome (PCOS), metabolic and cardiovascular dysfunction is related to hyper-
androgenic status and insulin resistance, however, Vitamin D3 has a beneﬁcial effect partly due to its anti-
oxidant capacity. Nitrative stress is a major factor in the development of cardiovascular dysfunction and insulin
resistance in various diseases. Our aim was to determine the effects of vitamin D3 in a rat model of PCOS, partic-
ularly the pathogenic role of nitrative stress.
Main methods: Female Wistar rats weighing 100–140 g were administered vehicle (C), dihydrotestosterone
(DHT) or dihydrotestosterone plus vitamin D3 (DHT + D) (n = 10 per group). On the 10th week, acetylcholine
(Ach) induced relaxation ability of the isolated thoracic aorta rings was determined. In order to examine the pos-
sible role of endothelial nitric oxide synthase (eNOS) and cyclooxygenase-2 (COX-2) pathways in the impaired









Eperformed. Leukocyte smears, aorta and ovary tissue sections were also immunostained with anti-nitrotyrosineantibody to determine nitrative stress.
Key ﬁndings: Relaxation ability of aorta was reduced in group DHT, and vitamin D3 partly restored Ach induced
relaxation. eNOS labeling was signiﬁcantly lower in DHT rats compared to the other two groups, however COX-2
staining showed an increment. Nitrative stress showed a signiﬁcant increase in response to dihydrotestosterone,
while vitamin D3 treatment, in case of the ovaries, was able to reverse this effect.
Signiﬁcance:Nitrative stressmay play a role in the pathogenesis of PCOS and in the development of the therapeutic















The diagnostic criteria for polycystic ovary syndrome (PCOS),
besides polycystic ovary morphology, are hyperandrogenic status and
oligo-amenorrhea. Insulin resistance is a common metabolic sign in
PCOS, it occurs in 50–80% of all patients (Diamanti-Kandarakis, 2012).
The long-term consequences of PCOS are metabolic disorders and
cardiovascular diseases. PCOS affects 5%–8% of women in reproductive
age, and it is a leading cause of female infertility. Earlier studies demon-
strated the presence of vascular dysfunction in PCOS; it was previously
described that aortic relaxation ability is decreased (Keller et al., 2011;









3), http://dx.doi.org/10.1016encoded (Walch et al., 2008). Although PCOS is characterized by insulin
resistance, and in prediabetic conditions endothelial function is deteri-
orating along with decreasing NO bioavailability (Sydow et al., 2005),
earlier studies did not examine the possible changes in eNOS and
COX-2 expressions in PCOS.
Nitric oxide (NO) is a ubiquitous transmitter, modulating for exam-
ple local blood ﬂow, platelet aggregation and neural activity, and it also
plays a crucial role in the immune response. Peroxynitrite is a reactive
free radical that is produced from the diffusion-controlled reaction
between NO and superoxide anion (Pacher et al., 2007). Neither super-
oxide nor NO is highly toxic in vivo, because there are numerous mech-
anisms to minimize their accumulation. On the other hand when they
react and form peroxynitrite in a non-enzymatic manner, it becomes a
very potent oxidant agent. Peroxynitrite is able to damage proteins
and nucleic acid, leading to loss of function and DNA breaks (Beckman





































































































































in subacute inﬂammation, and in prediabetic states (Fallarino et al.,
2004; Grohmann et al., 2003; Zappulla, 2008).
Earlier data show that in PCOS the expression of both eNOS and
COX-2 is decreased (Elia et al., 2006) in the ovary. Our hypothesis was
that NO and vasodilator prostaglandins are produced independently
in the endothelium, and along with decreased NO bioavailability,
COX-2 expression can either increase as a counterregulatory mecha-
nism, or decrease as part of the hampered endothelial function.
The physiological level of vitamin D3 is 30–60 ng/L (Bloomgarden,
2011). About 40% of adult European population lives with D3
hypovitaminosis. As vitamin D3-need depends on body mass index,
and women with PCOS are usually overweight, D3 hypovitaminosis
affects about 80% of women suffering from PCOS (Li et al., 2011). Vita-
min D3 concentrations also show connection to estrogen levels in
PCOS (Lerchbaum and Obermayer-Pietsch, 2012). Vitamin D3 may be
also used as adjuvant therapy in PCOS, however earlier studies mainly
focused on calcium homeostasis (Thys-Jacobs et al., 1999). On the
other hand, the positive effects of vitamin D on cardiovascular function
(Yiu et al., 2011), inﬂammation (Mabley et al., 2007) and carbohydrate
metabolism (Kotsa et al., 2009) are well-known.
Our aimwas also to determine systemic and tissue-speciﬁc nitrative
stress (estimated by tyrosine nitration), besides the abundance of endo-
thelial relaxant producing enzymes: endothelial NO synthase (eNOS)
and cyclooxygenase-2 (COX-2) in a rat model of PCOS. We hypothe-
sized as well that nitrative stress is linked to vascular dysfunction in
PCOS, and vitamin D therapy is able to alter this effect.
Materials and methods
Animals
The investigation conforms to the Guide for the Care and Use of
Laboratory Animals published by the US National Institutes of
Health and was approved by the institutional Animal Care Com-
mission (IRB approval: 22.1/2960/003/2009). Our study was designed
after Manneras et al. (2007). As previously reported (Masszi et al.,
2012; Sara et al., 2012a) thirty 21–28 day-old female Wistar rats
(Semmelweis University Animal Colony, Budapest, Hungarywhich orig-
inated from Charles River Ltd.), weighing 100–140 g were randomized
into 3 treatment groups. Under anesthesia (by Nembutal 45 mg/kg)
continuous-release pellets containing 7.5 mg DHT (Innovative Research
of America, Sarasota, FL, USA) were applied subcutaneously for 20 rats.
Releases of 83 mg/d for 90 days are guaranteed by the manufacturer.
The effectiveness of the DHT treatment was validated using
Diasource DHT-RIA Kit (Diasource, Gmb, Brussels, Belgium). Ten an-
imals underwent shamoperations receiving pellets that did not contain
DHT (control group). After the surgical intervention, amixture of 20 mg
amoxicillin and 4 mg clavulanic acid (Augmentin; Glaxo Smith Kline,
Brentford, UK) in 0.2 mL saline solution was administered intramuscu-
larly to prevent infection. Ten DHT animals received 120 ng/100 g body
weight/week 1,25 (OH)2 D3 vitamin (Injectable Calcijex, 2 mg/mL; Ab-
bott Laboratories, Abbot Park, IL; USA DHT + D3 group) subcutaneous-
ly. No medical or surgical complications were observed. Conventional
rat chow and tap water were provided ad libitum. On the 8th week of
the experiment oral glucose tolerance test (OGTT) was performed in
short ether narcosis in order to assess insulin response. Blood glucose
and plasma insulin levels weremeasured 120 min after the administra-
tion of 20 mg glucose/100 g body weight, in gauge. Insulin response
was calculated as insulin concentration divided by the glucose concen-
tration 120 min after glucose load. After 10 weeks of DHT treatment,
heparinized venous blood was collected from v. cava caudalis (10 IU/
6 mL blood) of the anesthetized animals, then the rats were perfused
transcardially with 10 mL heparinized (10 IU/mL) Krebs' solution
(CaCl2 2.5 mM; MgSO4 1.17 mM; EDTA 0.027 mM; NaCl 119 mM;
NaHCO3 20 mM; KCl 4.7 mM; KH2PO4 1.18 mM; glucose 11 mM;
Sigma Aldrich, Saint Louis, MO, USA). Thoracic aorta (TA) segments ofPlease cite this article as: Masszi G, et al, Endothelial relaxationmechanism







3 mm length from each experimental group were placed in warmed
(37 °C) oxygenated (95% O2 balanced with 5% CO2, Lindegas, Répcelak,
Hungary) Krebs' solution. Isometric tensionwasmeasuredwith isomet-
ric transducers (610-M Multi Myograph System; Danish Myo Technol-
ogy, Aarhus, Denmark), digitized using BioPac A/D converter, stored
and displayed on computer. A tension of 1.5 g was applied and the
ringswere equilibrated for 60 min. Concentration-dependent relaxation
to acetylcholine (10−8 to 10−5 M) was measured after precontraction
with norepinephrine (5 × 10−8 M).
Immunohistochemistry
Ovaries and aorta rings of the animals were freshly ﬁxed for histo-
logical examinations. Circulating mononuclear cells were isolated
from whole blood using Histopaque-1083 according to the users' man-
ual (Sigma Aldrich). To demonstrate polycystic morphology, hematox-
ylin–eosin staining was performed on tissue sections of the ovaries.
Circulating leukocyte smears and parafﬁn-embedded sections of aortas
and ovaries – after deparafﬁnization and antigen retrieval (0.1 mmol/L
citrate buffer, pH 3, heating in microwave oven for 15 min) -–were
immunostained with polyclonal rabbit anti-nitrotyrosine antibody
(1:200; overnight, 4 °C, Millipore, Billerica, MA, USA). After antigen
retrieval aorta segments were also stained for endothelial NO synthase
(polyclonal rabbit anti-eNOS antibody, 1:60, 70 min, 37 °C, Abcam,
Cambridge, MA, USA) and cyclooxygenase-2 (polyclonal rabbit anti-
COX-2 antibody, 1:200, 70 min, 37 °C, Abcam, Cambridge, MA, USA).
Secondary labeling was achieved by using biotinylated anti-rabbit
goat antibody (Vector Laboratories, Burlingame, CA, USA; 30 min, RT).
Horseradish peroxidase conjugated avidin (Vectastain ABC kit, Vector
Laboratories, 30 min, RT) and black colored nickel-cobalt enhanced
diaminobenzidine (Vector Laboratories, 6 min, RT)were used to visual-
ize the labeling (Vector Laboratories). Sections and smears were
counterstained by the red colored Nuclear Fast Red (NFR, Sigma Al-
drich). Data collections were made by Zeiss AxioImager.A1 microscope
coupled with Zeiss AxioCAmMRc5 CCD camera. Staining intensity was
determined by MBF ImageJ for microscopy (McMaster Biophotonics
Facility, Ontario, Canada). In case of nitrotyrosine labeling the percent-
age of positively stained tissue area to total area of the section was
calculated. In case of eNOS and COX-2 antibodies the endothelial layer
of aortas was evaluated. To estimate the nitrotyrosine positivity of
circulating leukocytes, staining intensity was scored with a mark
between 1 and 10 by a blinded experimenter.
Statistical analysis
Results are reported as mean ± SEM. Variance analysis of data was
performed using one- and two-wayANOVAs,where appropriate. Statis-
tical signiﬁcance between groups was determined by Tukey's (immu-
nohistochemistry) or Bonferroni's (in case of vascular function) post
hoc tests. Probability values of P ≤ 0.05 were considered signiﬁcant.
Results
Dihydrotestosterone levels of DHT and DHT + D treated rats were
signiﬁcantly higher than in the control animals (C: 267.3 ± 14.1;
DHT: 370.9 ± 35.0; DHT + D: 438.4 ± 24.1 pg/mL; mean ± SEM,
p ≤ 0.05 C vs. DHT and DHT + D). As our team already conﬁrmed,
ovarian structure became polycystic, glucose metabolism was
compromised in dihydrotestosterone-challenged rats, and vitamin
D3 treatment prevented these negative effects of hyperandrogenic
status (Fig. 2, left column) (Sara et al., 2012a). In the 120th minute
of OGTT, insulin response (insulin/glucose) was signiﬁcantly elevated
in the DHT group, which was reduced by vitamin D3 (C: 93.3 ± 15.1;
DHT: 232.4 ± 57; DHT + D: 57.5 ± 2.7 μg/mol; mean ± SEM,
p ≤ 0.05 DHT vs. C and DHT + D). Norepinephrine induced contrac-


























Fig. 1. Vasoactivity of aortic segments. Panel A: norepinephrine induced contraction. Contractions caused by 10−5 M norepinephrine was unaffected by DHT and vitamin D3
treatments. Data are presented in the percentage of K+-induced contraction in the 3rd minute of hyperkalemic environment. (Each data point represents N = 8 rats. Data represented
as mean ± SEM.) Panel B: acetylcholine dose–response curve. Concentration-dependent relaxation to acetylcholine (10−8 to 10−5 M) after precontraction with norepinephrine
(5 × 10−8 M) was signiﬁcantly lower in DHT group (black circles) compared to controls (open circles). Vitamin D3 (open triangles) improved acetylcholine induced relaxation. (Each
data point represents N = 8 rats. Data represented as mean ± SEM, **: p ≤ 0.01 vs. Control; ***: p ≤ 0.001 vs. Control; ###: p ≤ 0.001 vs. DHT).
3G. Masszi et al. / Life Sciences xxx (2013) xxx–xxx(Masszi et al., 2012). The acetylcholine induced relaxation ability of the
aorta was deteriorated in the DHT group compared to controls, and
vitamin D3 treatment signiﬁcantly ameliorated this result (Fig. 1,
Panel B). In the DHT group, nitrative stress estimated by nitrotyrosine
formation was signiﬁcantly higher in the ovarian (C:4.42 ± 0.6, DHT:
21.47 ± 3.4 area%, Fig. 2, right column and Fig. 4, Panel B) and aortic
(C:0.39 ± 0.06, DHT: 1.41 ± 0.23 area%, Fig. 3, left column and Fig. 5,
Panel A) tissues as well as in circulating leukocytes (Fig. 4, Panel A).
Expression of endothelial NO synthase was lower than the control level
(Fig. 3, intermediate column and Fig. 5, Panel B), and – probably due to









Fig. 2. Representative images of ovarian structure and nitrotyrosine staining. Left column: h
immunohistochemistry; gray colored diffuse staining over the red NFR counterstaining sh
ovarian structure became polycystic, and nitrative stress indicated by nitrotyrosine staining
parallel with the development of polycystic morphology (DHT + D, bottom row).
Please cite this article as: Masszi G, et al, Endothelial relaxationmechanism
model of polycystic ovar..., Life Sciences (2013), http://dx.doi.org/10.1016D
 P
R
Oshowed antagonistic tendency in DHT animals (Fig. 3, right column andFig. 5, Panel C). Vitamin D3 treatment had a mosaic effect: in the ovaries
of the rats nitrotyrosine formation was reduced (DHT + D: 10.45 ± 1.5
area%) in parallel with themorphological protection (Fig. 2,right column
and Fig. 4, Panel B). Although glucosemetabolism returned to the control
level, general nitrative stress (that was investigated by leukocyte
nitrotyrosine levels) was rather stabilized than altered by vitamin D3
therapy (Fig. 4, Panel A). In case of the aorta, nitrotyrosine grade was
still elevated (DHT + D: 0.78 ± 0.17 area%) (Fig. 3, left column and
Fig. 5, Panel A), but the quantity of eNOS was reversed to the control
level (Fig. 3, intermediate column and Fig. 5, Panel B). At the same timeE
ematoxylin–eosin staining of ovarian sections (10×). Right column: anti-nitrotyrosine
ows nitrated proteins (20×). In hyperandrogenic rats (DHT group, intermediate row)
was signiﬁcantly higher than in controls. Vitamin D3 inhibited nitrotyrosine formation
























Fig. 3. Representative immunohistochemical images of aortas stained against nitrotyrosine, eNOS and COX-2. Aortic nitrotyrosine staining was signiﬁcantly higher in both
DHT-receiver groups. Vitamin D3 treatment did not change this trend (left column: gray colored diffuse staining over the red NFR counterstaining shows nitrated proteins). The
presence of endothelial NO synthase was lower in DHT group (middle column) and COX-2 expression showed a tendency for increment (right column). As a response to vitamin
D3 dosing, eNOS expression rose to the control level, but COX-2 presence was elevated. On eNOS and COX-2 stained vessels arrows show positively labeled endothelial cells. Positive
staining is represented in black; red colored NFR was used as counterstain. Cells indicated with the green arrow are magniﬁed in the bottom right corner of appropriate blocks.
(Scale bar, 50 μm.) (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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Low-grade chronic inﬂammation and consequent leukocytosis are
present in women with PCOS, reviewed in Duleba (2012) and
Gonzalez (2012). As a consequence, or as a cause, insulin resistance is
also a characteristic symptom of PCOS. Decrement of ovarian NO and
prostaglandin E (PGE) production (Elia et al., 2006) and endothelial
dysfunction due to diminished NO bioavailability are already described
(Keller et al., 2011; Lakhani et al., 2006). Our group recently published,
that arteriolar NO metabolism and NO-mediated vasorelaxation are se-
verely hampered in thismodel of polycystic ovary syndrome (Sara et al.,
2012a, 2012b, 2012c). However, on the level of resistance vessels, vita-
min D3 treatment failed to improve acetylcholine sensitivity. In theU
N
C
Fig. 4. Nitrative stress in circulating leukocytes and ovaries. Panel A. Level of nitrotyrosine
overall nitrative stress estimated by nitrotyrosine staining of circulating leukocytes was sign
niﬁcance. Panel B. Nitrotyrosine labeling of ovaries. On the contrary, D-vitamin therapy inhib
or N = 10 (DHT + D) rats. Data represented as mean ± SEM, *: p ≤ 0.05 vs. Control, ***:
Please cite this article as: Masszi G, et al, Endothelial relaxationmechanism
model of polycystic ovar..., Life Sciences (2013), http://dx.doi.org/10.1016Epresent study we demonstrated that acetylcholine-induced relaxation
ability of the thoracic aorta is impaired ex vivo in our model of PCOS.
Inﬂammation leads to increased oxidative–nitrative stress. To esti-
mate systemic nitrative stress, our team measured tyrosine nitration in
circulating leukocytes. The isolation method allowed us to accumulate
lymphocytes in the samples. As lymphocytes have long half-life, they
have stronger defense mechanisms against oxidative–nitrative stress
compared to macrophages and polymorphonuclear cells. Our results
are consistent with the theory of chronic inﬂammation, showing stron-
ger nitrotyrosine staining in circulating mononuclear cells. Also, in the
ovaries and aortic tissue (both endothelial cells and smooth muscle
layers) we found stronger tyrosine nitration in rats. Parallel with our
work, Abdollahi's research group published, that lipid peroxidation
and peroxynitrite levels are elevated after 21 days of hyperandrogenous
state. They also found that the production of inﬂammatory cytokines is
elevated in the rat model of polycystic ovary syndrome (Rezvanfar
et al., 2012a; Rezvanfar et al., 2012b). Our results together with theirstaining of circulating leukocytes. In dihydrotestosterone-receiving rats (DHT group)
iﬁcantly higher than in controls. Vitamin D3 treatment (DHT + D) only diminished sig-
ited nitrotyrosine formation in the ovaries. (Each data point represents N = 9 (C, DHT)
p ≤ 0.001 vs. Control, #: p ≤ 0.05 vs. DHT.)






























































































Fig. 5. Evaluation of the immunohistochemical staining of the aortas. Panel A. Nitrotyrosine labeling of the vessel wall. Panel B. Endothelial eNOS staining. Panel C. Endothelial
COX-2 labeling. In control group, nitrotyrosine and inducible COX levels were low, and eNOS staining was strong. Elevation of DHT resulted in a three-fold increase in nitrotyrosine
and a two-fold increase in COX-2 staining intensity, while eNOS levels signiﬁcantly decreased. Vitamin D3 dosage inhibited the elevation in nitrotyrosine formation and decrement
of eNOS transcription, although it also caused a threefold increase in COX-2 staining compared to controls. (Each data point represents N = 10 (C, DHT) or N = 9 (DHT + D) rats.
Data represented as mean ± SEM, *: p ≤ 0.05 vs. Control, ***: p ≤ 0.001 vs. Control, #: p ≤ 0.05 vs. DHT.)








observations, which state that nitrative stress is signiﬁcantly higher in
PCOS, underlines the theory that oxidative–nitrative stress and inﬂam-
matory responses may have an important role in the pathogenesis of
PCOS. They also found that ovarian estrogen and progesterone levels
were reduced, while concentration of prostaglandin E was elevated in
the ovaries of rats with PCOS.
In the reproductive tract vitaminD3 is an important agent for estrogen
biosynthesis (Kinuta et al., 2000). Hyperandrogenic environment, com-
bined with low vitamin D3 level, leads to explicit ovarian hypofunction.
Vitamin D3 supplementation in our model controlled ovarian morpholo-
gy (Masszi et al., 2012; Sara et al., 2012a) and nitrotyrosine formation.
There is strong evidence that vitamin D3 is involved in both insulin secre-
tion and insulin receptor expression (Maestro et al., 2003; Oh and
Barrett-Connor, 2002; Ortlepp et al., 2001; Zeitz et al., 2003). Whereas
according to Ardabili et al. (2012), 3 months of vitamin D3 supplementa-
tion failed to improve insulin resistance (but insulin secretion) inwomen
with PCOS, in our model insulin sensitivity was normalized (Sara et al.,
2012a). Themajor differences between the two studies– besides the sub-
jects – were the onset (young adult women vs. adolescent rats) and the
dosage of vitamin D3 supplementation. In their study the target value
for vitamin D3 was over 20 ng/mL (average: 23.4 ng/mL), so in their
study they supplemented vitaminD froma severe to amild vitaminDde-
ﬁcient state. Hipponen et al. and Pittas et al. found a protective effect of
vitamin D intake against the development of both type 1 and type 2 dia-
betes mellitus (Hipponen et al., 2001; Pittas et al., 2006). Vitamin D3 also
lowers low-density lipoprotein and decreases cardiovascular risk in
women with PCOS (Thomson et al., 2012). Vitamin D3 also shows an
anti-inﬂammatory effect (Capri et al., 2006; Krishnan and Feldman,
2010; Mabley et al., 2007) and a cardiovascular protection (Zittermann
et al., 2005). As previous research showed, vitamin D3 was able to trigger
estrogen synthesis and also, downregulated aromatase expression,
followed by a decrease of proinﬂammatory cytokines in macrophages
(Villaggio et al., 2012). Asweproved, vitaminD3 therapy signiﬁcantly en-
hanced aortic response to acetylcholine, therefore improved endothelial
function. However, this inﬂuence of vitamin D3 exerted limited results,
for acetylcholine induced relaxation was below control level. As vitamin
D3 has complex and diverse effects, further studies would be required
to clarify the involved mechanisms and pathways.
Although in our PCOS rat model, vitamin D3 treatment failed to de-
crease the systemic nitrative stress signiﬁcantly, a statistical trend was
discernible. These data suggest that low-grade inﬂammation was still
present. As thoracic aorta endures the highest mechanical stress in the
vascular system, and systemic nitrotyrosine formationwas still elevated
in vitamin D3 treated group, higher level of nitrotyrosine staining is
comprehensible in the aorta.
Walch et al. demonstrated in a human study that eNOS genotype is
probably independent of PCOS (Walch et al., 2008). Endothelial NOPlease cite this article as: Masszi G, et al, Endothelial relaxationmechanism






synthase level was signiﬁcantly lower in the DHT group, explaining
whyNO-dependent relaxation abilitywas below the control groups. Be-
sides, Skogastierna et al., recently published, that testosterone in
supraphysiological doses inhibits eNOS expression but also increases
NO production (Skogastierna et al., 2013). This allows us to conclude
that the source of the elevated peroxynitrite levels is more likely the in-
ducible, and not the endothelial isoform of NO synthase (Elia et al.,
2006; Perreault andMarette, 2001; Shimabukuro et al., 1997). This phe-
nomenon partly explains the altered effectiveness of blood pressure
control mechanisms in women with PCOS. Also, lowered eNOS expres-
sion increases the risk of ischemia–reperfusion injury, as a consequence
of elevated risk of thrombosis. Probably as a compensatorymechanism,
COX-2 staining was twofold stronger in the DHT rats compared to the
baseline. The present study demonstrates the reverse changes in eNOS
and COX-2 levels in PCOS in the aortic endothelium for the ﬁrst time.
As a result of vitamin D3 treatment, eNOS expression was signiﬁcantly
higher than in the DHT group, and did not differ from the controls.
The fact that quasi normal eNOS translation did not result in control
level relaxation, and as systemic as well as local aortic nitrotyrosine
levels were not lowered by vitamin D3 supplementation, allows us to
draw the conclusion that low-grade inﬂammationmight be still present
during vitamin D3 therapy. COX-2 expression in vitamin D3 group
remained elevated compared to the control group, probably to compen-
sate challengedNO-bioavailability.We can hypothesize that the cause is
the decrement of eNOS expression and the effect is the elevation of
COX-2 translation. At the molecular level, vitamin D3 treatment in-
creases eNOS expression (Xiang, 2011), possibly due to receptor-
mediated mechanisms, leading to improved responsiveness to acetyl-
choline and relaxation ability.Conclusion
This is theﬁrst study to demonstrate the linked changes in eNOS and
COX-2 levels in PCOS in the aortic endothelium. This phenomenon
might partly explain – besides elevated cardiovascular risk – the altered
effectiveness of blood pressure control mechanisms in women with
PCOS.
Our results also conﬁrm the advantageous effects of adjuvant vita-
min D3 therapy in PCOS. On the level of ovaries and carbohydrate me-
tabolism we could detect an almost complete reversal of the damages
caused by DHT. As previous research showed, vitamin D3 is able to
trigger estrogen synthesis too. The beneﬁcial effect of vitamin D3 sup-
plementation in controlling the vascular and systemic nitrative stress
is not clear, but at the molecular level, vitamin D3 treatment increased
eNOS expression, leading to an improved responsiveness to acetyl-
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